Geratherm Medical AG Inhaber-Aktien o.N.
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
16.35%
Market Cap
14.34 Mil.
P/E Ratio
0.00
Dividend Yield
3.46 %
Earnings per Share
-0.15 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 2.65 G | 0 Units |
| PRICE DETERMINATION TIME | 06/24/2026 / 09:55:42 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 2.68 | 2.65 |
| PREV. DAY'S PRICE | 2.66 | (06/23) |
| CHANGE DAY BEFORE | -0.01 | -0.38 % |
| 52 WEEK HIGH / LOW | 8.44 (10/02) | 2.5 (04/14) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 0.07 | 0.02 | -0.15 | 0.13 | 0.21 |
| DIVIDENDS PER SHARE | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
| DIVIDEND YIELD IN % | - | - | 3.46 % | 2.87 % | 1.85 % |
| DIVIDEND GROWTH IN % | - | - | 0.00 % | 0.00 % | -33.33 % |
| PRICE - EARNINGS RATIO | 39.00 | 136.50 | - | 26.71 | 26.30 |
| PRICE - BOOK RATIO | - | - | 0.79 | 0.89 | 1.30 |
| PRICE - SALES RATIO | - | - | 1.05 | 1.35 | 1.39 |
| PRICE - CASH FLOW RATIO | - | - | 11.28 | 9.94 | 20.42 |
Master Data
| WKN | 549562 |
| ISIN | DE0005495626 |
| SYMBOL | GME |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Geratherm |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 5.41 Mil. |
| MARKET CAPITALISATION | 14.34 Mil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.38 % | -1.12 % | 3.50 % | -6.34 % | -16.35 % | -60.30 % | -74.79 % | -7.96 % |
| HIGH | 2.76 | 2.85 | 2.94 | 3.09 | 8.44 | 8.44 | 11.25 | 3.01 |
| LOW | 2.63 | 2.57 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
Dividend
per share
Company profile
Geratherm Medical AG engages in the manufacture and distribution of medical technology products used for temperature management and medical diagnostics. It operates through the following business segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke, and Respiratory. The Healthcare Diagnostic segment manufactures and supplies clinical thermometers, blood pressure monitors, and women's health products. The Medical Warming Systems segment sells incubators and warming systems used for surgeries and emergency responses. The Cardio/Stroke segment offers medical technology products that are designed to prevent strokes. The Respiratory segment develops, produces, and sells products used in pulmonary function and cardiopulmonary exercise testing. The company was founded in 1990 and is headquartered in Geratal, Germany.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
(in 29 days)
07/24/26Shareholders Meeting
(in 63 days)
08/27/26Q2 2026 Earnings Release
(in 67 days)
08/31/26Investor Meeting - Day 1
(in 68 days)
09/01/26Investor Meeting - Day 2
(in 306 days)
04/27/27Q4 2026 Earnings Release